SUBSTITUTED-ARYL COMPOUNDS FOR TREATMENT OF DISEASE

Details for Australian Patent Application No. 2003210730 (hide)

Owner PHARMACIA AND UPJOHN COMPANY

Inventors JACOBSEN, Jon, E.; ACKER, Brad, A.; MYERS, Jason, K.; GROPPI, Vincent, E., Jr.; WALKER, Daniel, P.; PIOTROWSKI, David, W.

Pub. Number AU-A-2003210730

PCT Number PCT/US03/02673

PCT Pub. Number WO2003/070728

Priority 60/357,465 15.02.02 US; 60/358,083 20.02.02 US; 60/357,472 15.02.02 US

Filing date 10 February 2003

Wipo publication date 9 September 2003

International Classifications

C07D 453/02 Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 025/00 Drugs for disorders of the nervous system

C07D 471/08 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/08 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 209/94 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/357,465 15.02.02 US; 60/358,083 20.02.02 US; 60/357,472 15.02.02 US

9 October 2003 Application Open to Public Inspection

  Published as AU-A-2003210730

4 November 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003210731-Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use

2003210729-Laminate for improved bonding